(Q39513352)

English

Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex

scientific article published on 2 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

thyroid carcinoma

1 reference

based on heuristic

inferred from title

anaplastic thyroid carcinoma

1 reference

based on heuristic

inferred from title

apoptotic process

1 reference

based on heuristic

inferred from title

author name string

Young Chang Lim

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Yun Yi Cha

2

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

publication date

2 July 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

104

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

776-780

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Epidermal growth factor receptor (EGFR) signaling in cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

EGFR signaling and drug discovery.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Cancer chemoprevention with dietary phytochemicals

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Mutations of the BRAF gene in human cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

(-)-Epigallocatechin-3-gallate inhibits Met signaling, proliferation, and invasiveness in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Cell cycle, CDKs and cancer: a changing paradigm

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Cellular proliferation, apoptosis and angiogenesis: molecular targets for nutritional preemption of cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.21999

21 January 2018

Identifiers

10.1002/JSO.21999

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39513352&oldid=1833839077"